Wu Hui, Ouyang Quchang, Tian Can, Xie Ning, Cao Min, Shui Zheng-Rong
Clin Lab. 2017 Jan 1;63(1):67-72. doi: 10.7754/Clin.Lab.2016.160535.
Although various individual studies have evaluated the correlation between cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer, the results remain inconclusive. To further evaluate the influence of CYP1A1 polymorphisms on breast cancer risk, we conducted a meta-analysis in the Chinese population.
Studies were identified using PubMed and Chinese databases through December 2015. Pooled odd ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strengths of these associations.
This meta-analysis included 6 studies with 1837 breast cancer cases and 1970 controls. No significant association of CYP1A1 T3801C polymorphism and breast cancer was observed in the Chinese population (C vs. T: OR = 1.01, 95% CI = 0.74 - 1.37; CC vs. TT: OR = 1.08, 95% CI = 0.65 - 1.78; CC vs. TT + CT: OR = 1.02, 95% CI = 0.84 - 1.24; CC + CT vs. TT: OR = 1.01, 95% CI = 0.63 - 1.60). The pooled estimate for CYP1A1 A2455G polymorphism was not statistically significantly associated with breast cancer in overall and subgroup analyses.
This meta-analysis provided evidence that CYP1A1 T3801C and A2455G variants might not be risk alleles for breast cancer susceptibility in Chinese individuals. Further studies conducted in other ethnic groups are required for definite conclusions.
尽管已有多项独立研究评估了细胞色素P450 1A1(CYP1A1)基因多态性与乳腺癌之间的相关性,但其结果仍无定论。为进一步评估CYP1A1基因多态性对乳腺癌风险的影响,我们在中国人群中进行了一项荟萃分析。
通过检索PubMed和中文数据库确定截至2015年12月的研究。采用合并比值比(OR)和95%置信区间(CI)评估这些关联的强度。
该荟萃分析纳入了6项研究,共1837例乳腺癌病例和1970例对照。在中国人群中,未观察到CYP1A1 T3801C基因多态性与乳腺癌之间存在显著关联(C与T比较:OR = 1.01,95%CI = 0.74 - 1.37;CC与TT比较:OR = 1.08,95%CI = 0.65 - 1.78;CC与TT + CT比较:OR = 1.02,95%CI = 0.84 - 1.24;CC + CT与TT比较:OR = 1.01, 95%CI = 0.63 - 1.60)。在总体和亚组分析中,CYP1A1 A2455G基因多态性的合并估计值与乳腺癌无统计学显著关联。
该荟萃分析表明,CYP1A1 T3801C和A2455G变异可能不是中国人群乳腺癌易感性的风险等位基因。需要在其他种族群体中进行进一步研究以得出明确结论。